ANXA1 and injury: We also found that ANXA1 (Ac2-26) significantly reduced CLP- or LPS-induced pathological kidney injury, improved kidney function, improved the 7-day survival rate, and increased HK-2 cell viability in vivo and in vitro (Figs. 2C, 8).